{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-24-000005","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.863369+00:00","generated_at":"2026-06-07T02:20:02.568358+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Evolent reaffirms FY2023 guidance; announces two new contract wins","bullets":["Reaffirmed previously issued revenue and Adjusted EBITDA guidance for Q4 and full year 2023.","Secured new partner logo in the Southwest for its technology and services suite.","Cross-sold NIA services to a legacy Evolent client in the Northeast."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-24-000005","json":"https://secwatch.observer/filing/0001628908-24-000005.json","markdown":"https://secwatch.observer/filing/0001628908-24-000005.md","text":"https://secwatch.observer/filing/0001628908-24-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000005/0001628908-24-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000005/evh-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:20:02.568358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}